EDGAR Filing Documents for 0001615774-17-004563

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001615774-17-004563

Filing Date

2017-08-18

Accepted

2017-08-18 15:40:47

Documents

Period of Report

2017-08-16

Document Format Files

Seq	Description	Document	Type	Size
1	4	s107264_form4.html	4
1	4	s107264_form4.xml	4	10851
	Complete submission text file	0001615774-17-004563.txt		12339

Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022

Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894

Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022

Business Address

Type: 4 | Act: 34 | File No.: 001-36019 | Film No.: 171041060